EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter, double-blind, randomized, placebo-controlled, two-arm parallel-group trial of GP 47779 , administered intravenously, to inpatients with epilepsy who are undergoing evaluation for epilepsy surgery



Multicenter, double-blind, randomized, placebo-controlled, two-arm parallel-group trial of GP 47779 , administered intravenously, to inpatients with epilepsy who are undergoing evaluation for epilepsy surgery



Neurology 58(7 Supplement 3): A293, April 9




(PDF 0-2 workdays service: $29.90)

Accession: 035349972

Download citation: RISBibTeXText



Related references

Evaluation of the antihypertensive effects of the angiotensin II antagonist tasosartan A randomized, double-blind placebo-controlled, dose ranging, parallel-group, multicenter trial. Clinical & Investigative Medicine 20(4 SUPPL ): S38, 1997

Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled trial. American Heart Journal 137(6): 1062-1069, June, 1999

Efficacy and safety of intravenously administered dofetilide in the acute termination of atrial fibrillation and flutter A multicenter, randomized, double-blind, and placebo-controlled trial. Journal of the American College of Cardiology 29(2 SUPPL A): 442A, 1997

Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial. Menopause 20(1): 28-37, 2013

A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. American Journal Of Hypertension. 11(4 Part 1): 454-461, Il, 1998

A double-blind, placebo-controlled, randomized multicenter trial of GABAPENTIN in pediatric patients with benign childhood epilepsy with centrotemporal spikes. Epilepsia 36(SUPPL 4): 125, 1995

Efficacy of a pre-thickened infant formula: a multicenter, double-blind, randomized, placebo-controlled parallel group trial in 104 infants with symptomatic gastroesophageal reflux. Clinical Pediatrics 42(6): 483-495, 2003

Treatment of separation anxiety in dogs with clomipramine: results from a prospective, randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial. Applied Animal Behaviour Science 67(4): 255-275, 2000

Efficacy and safety of celecoxib compared with placebo and etodolac for acute postoperative pain: a multicenter, double-blind, randomized, parallel-group, controlled trial. Nagoya Journal of Medical Science 77(1-2): 81-93, 2015

A double-blind, randomized, placebo-controlled trial of a diazepam auto-injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures. Epilepsia 54(11): 1968-1976, 2014

A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group. American Journal of Hypertension 11(4 Pt 1): 454-461, 1998

Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group. American Heart Journal 137(6): 1062-1069, 1999

Efficacy and safety of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 24-weeks: a multicenter, randomized, double-blind, parallel-group, placebo controlled trial. Plos One 9(4): E92843-E92843, 2015

Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder. Current Therapeutic Research, Clinical and Experimental 70(6): 405-420, 2009

The Efficacy and Safety of Wenxin Keli in Patients with Frequent Premature Ventricular Contractions: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial. Chinese Medical Journal 128(19): 2557-2564, 2016